List of Tables
Summary Table: Global Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 1: Report Scope
Table 2: Examples of Medical Software Under the European Union
Table 3: Medical Software Regulations
Table 4: Investments in 3D Medical and Surgical Imaging
Table 5: Common Robot-Assisted, Minimally Invasive Surgeries
Table 6: Common (Non-robot) Assisted Minimally Invasive Surgeries
Table 7: Benefits of 3D Imaging Techniques for Patient and Physicians
Table 8: Global Geriatric Population (60 Years+), by Region, 2015-2050
Table 9: 10 Leading Causes of Burden of Disease Worldwide, 2004 vs. 2030
Table 10: Key Investments in Medical Imaging Systems and Technologies Since 2015
Table 11: Global Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 12: Comparison of the Configurations of Preamplifiers Used in Imagers
Table 13: Global Market for 3D Medical and Surgical Imaging Platform Hardware, by Region, Through 2023
Table 14: Global Deaths from Cancer, 2015 and 2030
Table 15: Global Deaths from CVD, 2015 and 2030
Table 16: Global CVD Deaths, 2015
Table 17: Global Market for 3D Medical and Surgical Imaging Platform Software, by Region, Through 2023
Table 18: 3D Medical and Surgical Imaging Services
Table 19: Global Market for 3D Medical and Surgical Imaging Platform Services, by Region, Through 2023
Table 20: Global Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 21: Some Major Uses of Ultrasound
Table 22: Global Market for the Application of 3D Medical and Surgical Imaging Platforms in Ultrasound Systems, by Region, Through 2023
Table 23: Global Market for the Application of 3D Medical and Surgical Imaging Platforms in Digital Radiography, by Region, Through 2023
Table 24: Global Percentage Distribution of Population Aged above 65, by Region, 2015 and 2050
Table 25: Oral Cavity and Pharynx Cancer as a Percentage of All New Cancer Cases in the U.S., 2018
Table 26: New Cases of Oral Cavity and Pharynx Cancer, by Age Group 2011-2015
Table 27: Global Market for the Application of 3D Medical and Surgical Imaging Platforms in MRI Systems, by Region, Through 2023
Table 28: Global Number of Deaths Caused by Selected Chronic Diseases, 2015
Table 29: Rising Chronic Diseases in the United States, 2000-2030
Table 30: Global Market for the Application of 3D Medical and Surgical Imaging Platforms in Computed Tomography Systems, by Region, Through 2023
Table 31: Top 10 Causes of Death, 2016
Table 32: Percentage of Global Population with Cancer, 2005-2016
Table 33: Global Market for the Application of 3D Medical and Surgical Imaging Platforms in Nuclear Imaging Systems, by Region, Through 2023
Table 34: Number of DALYs for Neurological Disorders and as Percentage of Global DALYs Projected for 2005, 2015 and 2030
Table 35: Deaths Attributable to Neurological Disorders, 2005, 2015 and 2030
Table 36: YLDs Associated with Neurological Disorders and Other Diseases and Injuries with Neurological Sequelae Projected for 2005, 2015 and 2030
Table 37: Global Market for the Application of 3D Medical and Surgical Imaging Platforms Mammography Systems, by Region, Through 2023
Table 38: Recent Strategic Initiatives of Key Market Players
Table 39: Age-Specific Probabilities of Developing Invasive Female Breast Cancer, 2013-2023
Table 40: Top 10 Countries with the Highest Rate of Breast Cancer in 2018
Table 41: Incidence of Breast Cancer versus Total Cancer Incidence, 2015
Table 42: Comparison of Endoscopic Systems
Table 43: Global Market for the Application of 3D Medical and Surgical Imaging Platforms in Endoscopy, by Region, Through 2023
Table 44: Global Disease Burden Rates, by Cancer Type, 2016
Table 45: Global Market for 3D Medical and Surgical Imaging Platforms in Other Applications, by Region, Through 2023
Table 46: Advantages of Laparoscopic Surgery over Conventional Open Surgery
Table 47: Benefits and Drawbacks of On-premise, Cloud-based and Web-based Platforms
Table 48: Global Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 49: Global Market for On-premise 3D Medical and Surgical Imaging Platforms, by Region, Through 2023
Table 50: Companies That Offer Novel On-premise 3D Medical and Surgical Imaging Platforms with Features
Table 51: Benefits and Drawbacks of On-premise 3D Medical and Surgical Imaging Platforms
Table 52: Benefits and Drawbacks of Cloud-Based 3D Medical and Surgical Imaging Platforms
Table 53: Companies That Offer Cloud-based 3D Medical and Surgical Imaging Platforms with Features
Table 54: Global Market for Cloud-based 3D Medical and Surgical Imaging Platforms, by Region, Through 2023
Table 55: U.S. Medical and Health Research Expenditures, by Vertical, 2015 and 2016
Table 56: Benefits and Drawbacks of Web-based 3D Medical and Surgical Imaging Platforms
Table 57: Companies That Offer Web-based 3D Medical and Surgical Imaging Platforms with Features
Table 58: Global Market for Web-based 3D Medical and Surgical Imaging Platforms, by Region, Through 2023
Table 59: Global Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 60: Global Market for 3D Medical and Surgical Imaging Platforms in Hospitals, by Region, Through 2023
Table 61: Most Common Cancers Causing Death Globally, by Type, 2015
Table 62: Estimated Female Breast Cancer Deaths in the U.S., by Age, 2017
Table 63: U.S. Hospitals, by Type, 2016
Table 64: Global Prevalence of Dementia, 2015-2050
Table 65: Minimally Invasive Cosmetic Surgeries Across the Globe, 2016-2017
Table 66: Global Market for 3D Medical and Surgical Imaging Platforms in Ambulatory Healthcare Settings, by Region, Through 2023
Table 67: Global Market for 3D Medical and Surgical Imaging Platforms in Diagnostic Centers, by Region, Through 2023
Table 68: Technological Advancements, 2015-2018
Table 69: Advanced Product Development, 2015 and 2018
Table 70: Global Healthcare Expenditure, 2012 and 2015
Table 71: Distribution of Healthcare Expenditures, by Country, 2017
Table 72: Alzheimer’s Dementia in the United States, by Age Group, 2017
Table 73: Global Causes of Mortality, by Gender, 2015 (or Nearest Year)
Table 74: Global Market for 3D Medical and Surgical Imaging Platform in Research Centers, by Region, Through 2023
Table 75: Estimated U.S. Medical and Health Research Expenditures, Federal Government Agencies, 2014 and 2015
Table 76: R&D Expenditures, by Selected Scientific Agencies, 2015
Table 77: German Government R&D Spending, by Research Area, 2016 and 2017
Table 78: North American Market for 3D Medical and Surgical Imaging Platforms, by Country, Through 2023
Table 79: U.S. Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 80: U.S. Market for 3D Medical and Surgical Imaging Platforms, by Deployment, Through 2023
Table 81: U.S. Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 82: U.S. Estimated New Cancer Cases (Males), by Type, 2017
Table 83: U.S. Estimated New Cancer Cases (Females), by Type, 2017
Table 84: 10 Most Common Chronic Conditions for Adults 65+
Table 85: Chronic Disease, 2005-2030
Table 86: U.S. Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 87: Canadian Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 88: Canadian Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 89: New Cancer Cases and Estimated Deaths in Canada, 2016
Table 90: Canadian Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 91: Canadian Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 92: Total Healthcare Expenditure in Europe, by Category, 2018
Table 93: European Market for 3D Medical and Surgical Imaging Platforms, by Country, Through 2023
Table 94: U.K. Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 95: Deaths from CVD and Number of People Living with CVD in the United Kingdom, 2015-2017
Table 96: U.K. Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 97: U.K. Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 98: U.K. Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 99: French Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 100: Musculoskeletal Disorders in France, by Variable Type, 2016
Table 101: French Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 102: French Health Spending and Financing, 2005-2015
Table 103: French Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 104: French Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 105: Frequency of Cardiac Procedures in Germany, 2016
Table 106: German Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 107: Geriatric Population in Germany, 2015-2030
Table 108: German Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 109: German Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 110: German Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 111: Hospitals in Germany, by Category, 2015 and 2016
Table 112: Estimates of Cancer Incidence in Spain, by Type of Cancer, 2015
Table 113: Spanish Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 114: Spanish Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 115: Spanish Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 116: Spanish Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 117: ROE Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 118: ROE Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 119: ROE Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 120: ROE Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 121: Breast Cancer in Norway, 2014 and 2015
Table 122: Asia Pacific Market for 3D Medical and Surgical Imaging Platforms, by Country, Through 2023
Table 123: Chinese Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 124: Chinese Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 125: Chinese Cancer Prevalence, by Gender and Type, 2016
Table 126: Current Chinese Cancer Grants, by Gender and Cancer Type, 2017
Table 127: Chinese Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 128: Healthcare Facilities in China, as of October 2016
Table 129: Chinese Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 130: Indian Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 131: Diagnostics Imaging Investments in India, 2016
Table 132: Indian Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 133: Indian Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 134: Number of Aesthetic Surgical Procedures Performed in India, 2016
Table 135: Indian Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 136: Japanese Aging Population and Future Estimates, 2010-2040
Table 137: Japanese Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 138: Japanese Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 139: Japanese Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 140: Japanese Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 141: Australian Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 142: 20 Most Commonly Diagnosed Cancers in Australia (Males), 2017
Table 143: 20 Most Commonly Diagnosed Cancers in Australia (Females), 2017
Table 144: 10 Most Common Causes of Death from Cancer in Australia (Male), 2017
Table 145: 10 Most Common Causes of Death from Cancer in Australia (Females), 2017
Table 146: Australian Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 147: Australian Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 148: Australian Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 149: Rest of Asia Pacific Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 150: Rest of Asia Pacific Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 151: Medical Tourism Revenue, Malaysia, 2011-2016
Table 152: Foreign Patients, Malaysia, 2011-2016
Table 153: Rest of Asia Pacific Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 154: Rest of Asia Pacific Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 155: Rest of the World Market for 3D Medical and Surgical Imaging Platforms, by Region, Through 2023
Table 156: ROW 60+ Population, by Region
Table 157: New Cases of Cancer, by Gender in Brazil, 2016
Table 158: Latin American Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 159: 60+ Population in Brazil, 2015-2050
Table 160: Latin American Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 161: Latin American Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 162: Projected Healthcare Spending in Argentina, 2014 and 2040
Table 163: Leading Causes of Death in Argentina and Percentage Change between 2005 and 2016
Table 164: Latin American Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 165: MEA Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 166: Department of Health, Abu Dhabi Cancer Screening Recommendations
Table 167: MEA 3D Market for Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 168: MEA Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 169: MEA Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 170: Innovations within the Industry
Table 171: 3D Medical and Surgical Imaging Instruments and Their Components
Table 172: Mandatory Regulatory Guidelines for Suppliers and Manufacturers
Table 173: Suppliers and Manufacturers for 3D Medical and Surgical Imaging Devices in the U.S.
Table 174: Suppliers and Manufacturers of 3D Medical and Surgical Imaging Devices in China
Table 175: Suppliers and Manufacturers of 3D Medical and Surgical Imaging Devices in the Rest of Asia-Pacific
Table 176: Suppliers and Manufacturers of 3D Medical and Surgical Imaging Devices in Europe
Table 177: Ambra Health: Product Portfolio
Table 178: Ambra Health: Recent Developments, 2018
Table 179: Arterys: Product Portfolio
Table 180: Arterys: Recent Developments, 2018
Table 181: Brainlab AG: Product Portfolio
Table 182: Canon Medical Systems Ltd.: Product Portfolio
Table 183: Canon Medical Systems Ltd.: Recent Development, 2018
Table 184: DePuy Synthes: Product Portfolio
Table 185: Esaote SpA: Product Portfolio
Table 186: Esaote SpA: Recent Development, 2017
Table 187: Fovia: Product Portfolio
Table 188: Fovia: Recent Developments, 2015-2017
Table 189: GE Healthcare: Product Portfolio
Table 190: GE Healthcare: Recent Developments, 2015-2017
Table 191: Kitware Inc.: Product Portfolio
Table 192: Koninklijke Philips NV: Product Portfolio
Table 193: Koninklijke Philips NV: Recent Development 2017 and 2018
Table 194: Lexmark International Inc.: Product Portfolio
Table 195: Mach7 Technologies Ltd.: Product Portfolio
Table 196: Mach7 Technologies Ltd.: Recent Developments, 2016 and 2017
Table 197: McKesson Corp.: Product Portfolio
Table 198: Medtronic Inc.: Product Portfolio
Table 199: Medtronic Inc.: Recent Developments 2015-2018
Table 200: Navegatium: Product Portfolio
Table 201: NDS Surgical Imaging LLC: Product Portfolio
Table 202: NerveVision Inc.: Product Portfolio
Table 203: Olympus Corp.: Product Portfolio
Table 204: Olympus Corp.: Recent Developments, 2017
Table 205: PIE Medical Imaging BV: Product Portfolio
Table 206: PIE Medical Imaging BV: Recent Developments, 2017 and 2018
Table 207: Planmeca OY: Product Portfolio
Table 208: Quibim SL: Product Portfolio
Table 209: Siemens Healthcare: Product Portfolio
Table 210: Siemens Healthcare: Recent Developments, 2017
Table 211: Stryker Corp.: Product Portfolio
Table 212: Stryker Corp.: Recent Developments, 2015
Table 213: Surgical Theater LLC: Product Portfolio
Table 214: Surgical Theater LLC: Recent Development, 2015
Table 215: WhiteClouds: Product Portfolio
Table 216: WhiteClouds: Recent Developments, 2016
List of Figures
Summary Figure: Global Market for 3D Medical and Surgical Imaging Platforms, by Component, 2017-2023
Figure 1: Annual Market Revenues for Robot-Assisted, Minimally Invasive Surgery, 2015-2025
Figure 2: Annual Market Revenues from Sales of Endoscopy Devices, 2015-2024
Figure 3: Cost Breakdown: Owning Hybrid Operating Rooms, by Equipment Type
Figure 4: Cloud Computing in Medical and Surgical Imaging
Figure 5: Trends in Rising Aged Population Around the World, 2014-2022
Figure 6: Trends in Number of Deaths Due to Chronic Diseases, 2005-2020
Figure 7: Rising Trends in Healthcare Spending, by Payment Source, 2015-2040
Figure 8: Block Diagram of LDS Imaging System
Figure 9: Structure of Software
Figure 10: Global Deaths from Cancer, 2015 and 2030
Figure 11: Global Deaths from CVD, 2015 and 2030
Figure 12: Global CVD Deaths, by Type, 2015
Figure 13: Global Percentage Distribution of Population Aged above 65, by Region, 2015 and 2050
Figure 14: Oral Cavity and Pharynx Cancer versus All New Cancer Cases in the U.S., 2018
Figure 15: Percentage of New Cases of Oral Cavity and Pharynx Cancer, by Age Group 2011-2015
Figure 16: Global Number of Deaths Caused by Selected Chronic Disease, 2015
Figure 17: Rising Chronic Diseases in the United States, 2000-2030
Figure 18: Top 10 Causes of Death, 2016
Figure 19: Percentage of Global Population with Cancer, 2005-2016
Figure 20: Application of 3D Medical and Surgical Imaging Platforms in Nuclear Imaging
Figure 21: Factors Affecting Breast Cancer Risk in Women
Figure 22: Top 10 Countries with the Highest Rate of Breast Cancer in 2018
Figure 23: Incidence of Breast Cancer versus Total Cancer Incidence, 2015
Figure 24: Global Disease Burden Rates, by Cancer Type, 2016
Figure 25: Applications of Laparoscopy
Figure 26: U.S. Medical and Health Research Expenditures, by Vertical, 2015 and 2016
Figure 27: Steps to Derive Final 3D Image through Web-based Surgical Imaging Platform
Figure 28: Major Market Drivers
Figure 29: Advantages of 3D Mammography versus 2D
Figure 30: Most Common Cancers Causing Death Globally, by Type, 2015
Figure 31: U.S. Hospitals, by Type, 2016
Figure 32: Global Prevalence of Dementia, 2015-2050
Figure 33: Minimally Invasive Cosmetic Surgeries Across the Globe, 2016-2017
Figure 34: Major Factors Driving the Growth of Global Diagnostic Centers Market
Figure 35: Applications of 3D Medical and Surgical Imaging Platforms in Diagnostic Centers
Figure 36: Global Healthcare Expenditure, 2012 and 2015
Figure 37: Distribution of Healthcare Expenditures, by Country, 2017
Figure 38: Alzheimer’s Dementia in the United States, by Age Group, 2017
Figure 39: Chronic Diseases, 2005-2030
Figure 40: Total Healthcare Expenditure in Europe, by Category, 2018
Figure 41: Musculoskeletal Disorders in France, by Variable Type, 2016
Figure 42: French Health Spending and Financing, 2005-2015
Figure 43: Geriatric Population in Germany, 2000-2030
Figure 44: Hospitals in Germany, by Category, 2015 and 2016
Figure 45: Role of Medical Radiation Imaging in Cancer Management
Figure 46: Breast Cancer in Norway, 2014 and 2015
Figure 47: Chinese Cancer Prevalence, by Gender and Type, 2016
Figure 48: Japanese Aging Population and Future Estimates, 2010-2040
Figure 49: 20 Most Commonly Diagnosed Cancers in Australia (Males), 2017
Figure 50: 20 Most Commonly Diagnosed Cancers in Australia (Females), 2017
Figure 51: Projected Healthcare Spending in Argentina, 2014 and 2040
Figure 52: Industry Structure for 3D Medical and Surgical Imaging Market
Figure 53: Factors Influencing Supplier Contracts Within 3D Medical and Surgical Imaging Market
Figure 54: Medical Technology R&D Process
Figure 55: R&D from Conceptualization to Development
Figure 56: Marketing Matrix for Medical Technology Products
Figure 57: Medical and Surgical Imaging Instruments Manufacturing Process
Figure 58: Global Healthcare Expenditure, by Institutional Spending, 2015-2025
Figure 59: Block-Chain Capabilities Across Supply Chain
Figure 60: Global Logistics Robotics Market Revenue Forecast, 2015-2021
